IRWD
Price
$3.26
Change
+$0.05 (+1.56%)
Updated
Dec 24 closing price
Capitalization
530.33M
48 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$13.75
Change
+$0.07 (+0.51%)
Updated
Dec 24 closing price
Capitalization
1.89B
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRWD vs PRGO

Header iconIRWD vs PRGO Comparison
Open Charts IRWD vs PRGOBanner chart's image
Ironwood Pharmaceuticals
Price$3.26
Change+$0.05 (+1.56%)
Volume$583.97K
Capitalization530.33M
Perrigo
Price$13.75
Change+$0.07 (+0.51%)
Volume$1.43M
Capitalization1.89B
IRWD vs PRGO Comparison Chart in %
IRWD
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IRWD vs. PRGO commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRWD is a Hold and PRGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (IRWD: $3.26 vs. PRGO: $13.75)
Brand notoriety: IRWD and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IRWD: 21% vs. PRGO: 35%
Market capitalization -- IRWD: $530.33M vs. PRGO: $1.89B
IRWD [@Pharmaceuticals: Generic] is valued at $530.33M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $1.89B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRWD’s FA Score shows that 0 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • IRWD’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRGO is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRWD’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • IRWD’s TA Score: 4 bullish, 4 bearish.
  • PRGO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than IRWD.

Price Growth

IRWD (@Pharmaceuticals: Generic) experienced а -3.26% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.58%. For the same industry, the average monthly price growth was +8.11%, and the average quarterly price growth was +22.96%.

Reported Earning Dates

IRWD is expected to report earnings on Feb 12, 2026.

PRGO is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.58% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($1.89B) has a higher market cap than IRWD($530M). PRGO has higher P/E ratio than IRWD: PRGO (2818.00) vs IRWD (18.11). IRWD YTD gains are higher at: -26.411 vs. PRGO (-44.714). PRGO has higher annual earnings (EBITDA): 598M vs. IRWD (129M). PRGO has more cash in the bank: 432M vs. IRWD (140M). IRWD has less debt than PRGO: IRWD (598M) vs PRGO (3.65B). PRGO has higher revenues than IRWD: PRGO (4.28B) vs IRWD (339M).
IRWDPRGOIRWD / PRGO
Capitalization530M1.89B28%
EBITDA129M598M22%
Gain YTD-26.411-44.71459%
P/E Ratio18.112818.001%
Revenue339M4.28B8%
Total Cash140M432M32%
Total Debt598M3.65B16%
FUNDAMENTALS RATINGS
IRWD vs PRGO: Fundamental Ratings
IRWD
PRGO
OUTLOOK RATING
1..100
644
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10090
PRICE GROWTH RATING
1..100
3565
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
5037

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (34) in the Pharmaceuticals Other industry is in the same range as IRWD (58). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

PRGO's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as PRGO (65). This means that IRWD’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for IRWD (100). This means that PRGO’s stock grew significantly faster than IRWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRWDPRGO
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 16 days ago
67%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
IRWD
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWQAX17.260.08
+0.47%
Transamerica Large Cap Value A
NCVLX12.490.04
+0.32%
Nuance Concentrated Value Institutional
PJGCX13.870.04
+0.29%
PGIM Jennison Focused Value C
TAVZX73.200.12
+0.16%
Third Avenue Value Z
PAITX21.15N/A
N/A
T. Rowe Price International Stock Adv

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+1.56%
ACET - IRWD
30%
Poorly correlated
+6.85%
PRGO - IRWD
29%
Poorly correlated
+0.51%
AMRX - IRWD
26%
Poorly correlated
+0.23%
ELAN - IRWD
24%
Poorly correlated
+0.72%
PAHC - IRWD
24%
Poorly correlated
+0.94%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ZTS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+0.51%
ZTS - PRGO
35%
Loosely correlated
+1.58%
ALKS - PRGO
33%
Poorly correlated
+0.11%
EOLS - PRGO
31%
Poorly correlated
+0.59%
ORGO - PRGO
30%
Poorly correlated
+2.09%
SUPN - PRGO
30%
Poorly correlated
+0.12%
More